"Subtilisins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of SERINE ENDOPEPTIDASES isolated from Bacillus subtilis. EC 3.4.21.-
| Descriptor ID |
D013381
|
| MeSH Number(s) |
D08.811.277.656.300.760.787 D08.811.277.656.959.350.787
|
| Concept/Terms |
Subtilisin BPN'- Subtilisin BPN'
- Subtilisin GX
- Subtilisin E
- Nagarse
- Subtilisin Novo
Subtilisin Carlsberg- Subtilisin Carlsberg
- Carlsberg Subtilisin
- Subtilisin, Carlsberg
- Subtilisin DY
- Subtilisin A
- Subtilopeptidase A
- Alcalase
- Novo Alcalase
- Alcalase, Novo
|
Below are MeSH descriptors whose meaning is more general than "Subtilisins".
Below are MeSH descriptors whose meaning is more specific than "Subtilisins".
This graph shows the total number of publications written about "Subtilisins" by people in this website by year, and whether "Subtilisins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2022 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Subtilisins" by people in Profiles.
-
Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT. Lancet Diabetes Endocrinol. 2022 10; 10(10):732-740.
-
Safety and efficacy of inclisiran in South African patients at high cardiovascular risk: A subanalysis of the ORION phase III clinical trials. S Afr Med J. 2022 05 31; 112(6):426-432.